FDA Revises Trial Requirements for Drug and Medical Product Approval - Part 1
In part one of this series, Dr. Justin Abbatemarco and Lizzy Lawrence discuss the FDA's shift toward single-trial drug approvals. Show citation
Read the full articleYou might also wanna read
Researchers Call for FDA to Require Negative Drug Studies on Product Labels After Approval of Drug with Mostly Negative Results
Researchers urge inclusion of negative studies on drug labels
medpagetoday.com·19d agoFDA Accepts New Drug Application for Oral Investigational Treatment in RRMM – Bristol Myers Squibb
Bristol Myers Squibb, shared a post on LinkedIn: “The U.S. FDA has accepted a New Drug Application for our second oral investigational treat
OncoDaily·3d ago
HHS and FDA announce reforms to accelerate clinical trials and restore US research leadership
A welcome move from the FDA and HHS
writingruxandrabio.com·24d agoFDA Issues Revised Draft Guidance on Demonstrating Substantial Evidence of Effectiveness for Human Drugs and Biological Products
On June 22, 2026, the U.S. Department of Health and Human Services (HHS) unveiled Operation TrialBlazer, a department-wide effort to acceler
Arnold & Porter·23d ago
People’s Pharmacy: FDA is changing prescribing info for testosterone replacement therapy. Here’s what to know
Have low T? FDA is loosening it's labeling rules.
oregonlive·5d ago
China's Rise in Global Clinical Trials: Regulatory Reforms and US Competitiveness
Theo Jaffee and Gabriel Dickinson speak with Cremieux about China’s rapid rise to the top of global clinical trial output. They discuss the
pca.st·25d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.